Author

Matthew W. VanBrocklin

University of UtahORCID 0000-0003-0114-3495Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 3 Approach:experimental assay· 3 Organism:human· 2 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

Dekker C. DeaconiD· 2 shared Sheri L. HolmeniD· 2 shared A. Paulina MedelliniD· 1 shared Adriene PavekiD· 1 shared Alexandra YoungiD· 1 shared Amanda JiangiD· 1 shared Anastasia Prokofyeva· 1 shared Aparna HegdeiD· 1 shared

Activity by Year

2024-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Dekker C. DeaconORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyCancer ResearchPeer-reviewedMay 22, 2026

Genetic Drivers of Sensitivity or Resistance to RAS(ON) Multi-Selective Inhibitors in NRAS-Mutated Melanoma

Mona Foth, Wontak Kim, Kayla T. O’Toole…·Martin McMahon

This study identifies RAS(ON) inhibitors effective against NRAS-mutated melanoma and reveals resistance mechanisms through Ppia and Map2k1 mutations.

5 citationstop 1%

humanexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintMar 21, 2026

Focal adhesion kinase promotes metastasis in BRAF-mutant melanoma

Karly A. Stanley, MiKaela N. Field, Adriene Pavek…·Sheri L. Holmen

This study shows FAK promotes metastasis in BRAF-mutant melanoma through kinase-dependent mechanisms downstream of PTEN, suggesting FAK inhibition could improve treatment outcomes.

DOI 10.64898/2026.03.19.712212

mouseexperimental assay

𝕏 PostBluesky

Pharmacology & ToxicologyJournal of Controlled ReleasePeer-reviewedOct 21, 2024

Transdermal Delivery of Ultradeformable Cationic Liposomes Complexed with miR211-5p (UCL-211) Stabilizes BRAFV600E+ Melanocytic Nevi

Tanya Chhibber, Michael T. Scherzer, Anastasia Prokofyeva…·Paris Jafari

This study develops UCL-211, a transdermal delivery system for miR211-5p, which stabilizes BRAFV600E+ melanocytic nevi by maintaining them in a growth-arrested state.

8 citations

humanexperimental assay

𝕏 PostBluesky